• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
PMV Pharma released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue: USD 0, actual EPS: USD -1.1408
04:00
PMV Pharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3973 (forecast USD -0.4025)
04:00
Nov12
TD Cowen Maintains Buy Rating on PMV Pharmaceuticals Stock
16:07
Oct27
OrbiMed Advisors LLC Reports Sale of PMV Pharmaceuticals Inc. Common Stock
21:20
Aug8
PMV Pharma released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4077 (forecast USD -0.385)
03:00
PMV Pharma released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -0.7434
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -21.06 M, EPS -0.3973

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.21 M, EPS -0.4077

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -17.44 M, EPS -0.3356

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCSA
6.018
+100.25%
+3.000
ATPC
0.1495
+66.11%
+0.059
YCBD
2.240
+56.64%
+0.810
VYNE
0.6208
+54.16%
+0.216
ISPO
4.170
+46.83%
+1.330
MGRT
7.560
+41.31%
+2.210
ANDG
20.950
+30.94%
+4.950
GVH
3.790
+28.47%
+0.840
TGL
7.815
+27.07%
+1.760
ADTX
1.760
+23.94%
+0.350
View More